The DOI matches its Crossref record.
Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16‐induced tumors
Open accessAbstract
Previously, we have shown that immunization with human papillomavirus (HPV) type 16‐derived cytotoxic T lymphocyte (CTL) epitope E7 49–57 (RAHYNIVTF) renders C57BL/6 mice insensitive to tumors formed by HPV16‐transformed cells. In this study, we provide evidence that E7 49–57 is expressed as a subdominant CTL epitope on HPV16‐transformed C57BL/6 cells. Using acid peptide elution, it is shown that HPV16‐transformed cells express another CTL epitope, besides E7 49‐57, which appears to be dominant. We demonstrate that a CTL line raised against the subdominant CTL epitope, offered as synthetic peptide E7 49–57, eradicates established HPV16‐induced tumors in mice. Our data show that synthetic peptide‐induced CTL can be applied successfully in vivo against (virus‐induced) tumor, and emphasize that subdominant CTL epitopes are useful targets for immunotherapy. Furthermore, it is illustrated for the first time that HPV16‐specific CTL interfere directly with HPV16‐induced tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Dendritic Cells in Cancer Immunotherapy
Fong, L., & Engleman, E. G. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.245 · Cited by 680
Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism
Sette, A., & Sidney, J. (1999) · Immunogenetics · doi:10.1007/s002510050594 · Cited by 635
Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells
Gabrilovich, D. I., Velders, M. P., Sotomayor, E. M., & Kast, W. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5398 · Cited by 538
Self-citationDiehl, L., den Boer, A. T., Schoenberger, S. P., van der Voort, E. I. H., Schumacher, T. N. M., Melief, C. J. M., Offringa, R., & Toes, R. E. M. (1999) · Nature Medicine · doi:10.1038/10495 · Cited by 469
Self-citationClay, T. M., Custer, M. C., Sachs, J., Hwu, P., Rosenberg, S. A., & Nishimura, M. I. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.507 · Cited by 410
Metadata
- Authors
- Feltkamp, M. C. W., Vreugdenhil, G. R., Vierboom, M. P. M., Ras, E., van der Burg, S. H., Schegget, J. T., Melief, C. J. M., & Kast, W. M.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1995-09
- Volume
- 25
- Issue
- 9
- Pages
- 2638-2642
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2042955728
- Cited by
- 166
- References
- 0
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16‐induced tumors. https://app.cochat.ai/papers/10.1002/eji.1830250935
- The paper
- Feltkamp, M. C. W., Vreugdenhil, G. R., Vierboom, M. P. M., Ras, E., van der Burg, S. H., Schegget, J. T., Melief, C. J. M., & Kast, W. M. (1995). Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16‐induced tumors. European Journal of Immunology. https://doi.org/10.1002/eji.1830250935
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.